Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Topline results from phase I study of vonapanitase in symptomatic peripheral artery disease

Aug. 14, 2015

Allogenic MPCs show safety in HF patients

Aug. 12, 2015

Cardioxyl Pharmaceuticals patents HNO donors

Aug. 12, 2015

German and U.S. team presents omega-3 PUFA analogues

Aug. 11, 2015

Promising antiatherosclerosis activity of human FOXP3 gene therapy in mice

Aug. 7, 2015

ISIS Pharmaceuticals presents preliminary data for ISIS-TTRRx

Aug. 6, 2015

Gene delivery therapy shows promising effects on experimental autoimmune myocarditis

Aug. 5, 2015

Abbott makes deals with heart valve device developers Tendyne and Cephea

Aug. 4, 2015

Merck & Co. discloses ROMK channel blockers

Aug. 4, 2015

Bayer starts pilot study of BAY-1142524 in left ventricular dysfunction after MI

Aug. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...